Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of MY004567 tablets in methotrexate-inadequate responder rheumatoid arthritis
CTR20231762Phase 2Completed
- Sponsor
- Meiyue Biotech
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MY-004 in rheumatoid arthritis (RA), sponsored by Meiyue Biotech. Started Jun 2023; status: completed.
02
Drugs
MY-004
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20231762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231762.